Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19

The outbreak of coronavirus disease 2019 (COVID-19) underlined the urgent need for alleviating cytokine storm. We propose here that activating the cholinergic anti-inflammatory pathway (CAP) is a potential therapeutic strategy. However, there is currently no approved drugs targeting the regulatory p...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Zhen, Xiang, Kefa, Su, Ding-Feng, Sun, Yang, Liu, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901247/
https://www.ncbi.nlm.nih.gov/pubmed/33633726
http://dx.doi.org/10.3389/fimmu.2020.595342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901247/
https://www.ncbi.nlm.nih.gov/pubmed/33633726
http://dx.doi.org/10.3389/fimmu.2020.595342

Ejemplares similares